Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

✍ Scribed by Abdelrahman, R A; Begna, K H; Al-Kali, A; Hogan, W J; Litzow, M R; Tefferi, A

• Book ID: 126603916
• Publisher: Nature Publishing Group
• Year: 2014
• Tongue: English
• Weight: 621 KB
• Volume: 29
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/leu.2014.286